Mckesson (MCK) Income from Non-Controlling Interests (2014 - 2026)
Mckesson (MCK) reported Income from Non-Controlling Interests of $173.0 million for Q1 2026, up 276.09% year-over-year from $46.0 million in Q1 2025, and up 170.31% quarter-over-quarter from $64.0 million in Q4 2025.
Mckesson (MCK) Income from Non-Controlling Interests (2014 - 2026) Analysis & Trends
Mckesson (MCK) has 13 years of Income from Non-Controlling Interests data on file, last reported at $173.0 million in Q1 2026.
- Income from Non-Controlling Interests for Q1 2026 came in at $173.0 million, up 276.09% year-over-year; the trailing twelve-month figure through Mar 2026 was $337.0 million (up 81.18% YoY), and the FY2026 annual result was $337.0 million, up 81.18% from the prior year.
- Income from Non-Controlling Interests rose to $173.0 million in Q1 2026 per MCK's latest filing, from $64.0 million in the prior quarter.
- Over five years, Income from Non-Controlling Interests peaked at $173.0 million in Q1 2026 and troughed at $37.0 million in Q1 2022.
- A 5-year average of $51.8 million and a median of $41.0 million in 2022 frame the typical range for Income from Non-Controlling Interests.
- The sharpest annual moves came in 2022 and 2026: Income from Non-Controlling Interests slipped 21.28% in 2022, then surged 276.09% in 2026.
- A 5-year view of Income from Non-Controlling Interests shows it stood at $41.0 million in 2022, then changed by 0.0% to $41.0 million in 2023, then increased by 19.51% to $49.0 million in 2024, then surged by 30.61% to $64.0 million in 2025, then surged by 170.31% to $173.0 million in 2026.
- Business Quant data shows MCK's Income from Non-Controlling Interests at $173.0 million in Q1 2026, $64.0 million in Q4 2025, and $53.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inc. Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Akso Health | 2,315,158.81 Bn | 2,315,158.63 Bn | - | - |
| 2 | Mckesson | 92.76 Bn | 89.18 Bn | 4.04 Bn | 173.00 Mn |
| 3 | Cencora | 52.82 Bn | 50.83 Bn | 3.59 Bn | -11.80 Mn |
| 4 | Cardinal Health | 52.17 Bn | 48.39 Bn | 2.50 Bn | -19.00 Mn |
| 5 | Henry Schein | 9.19 Bn | 9.71 Bn | 1.07 Bn | 5.00 Mn |
| 6 | Accendra Health | 246.88 Mn | -90.00 Mn | 312.39 Mn | - |
| 7 | Edap Tms | 161.92 Mn | 146.92 Mn | 8.15 Mn | - |
| 8 | 111 | 107.47 Mn | 25.61 Mn | 23.58 Mn | 30,000.00 |
| 9 | Cosmos Health | 9.42 Mn | 7.26 Mn | 1.38 Mn | - |
| 10 | Cellyan Biotechnology | 5.69 | -2.48 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 173.00 Mn |
| Dec 31, 2025 | 64.00 Mn |
| Sep 30, 2025 | 53.00 Mn |
| Jun 30, 2025 | 47.00 Mn |
| Mar 31, 2025 | 46.00 Mn |
| Dec 31, 2024 | 49.00 Mn |
| Sep 30, 2024 | 46.00 Mn |
| Jun 30, 2024 | 45.00 Mn |
| Mar 31, 2024 | 39.00 Mn |
| Dec 31, 2023 | 41.00 Mn |
| Sep 30, 2023 | 39.00 Mn |
| Jun 30, 2023 | 39.00 Mn |
| Mar 31, 2023 | 39.00 Mn |
| Dec 31, 2022 | 41.00 Mn |
| Sep 30, 2022 | 41.00 Mn |
| Jun 30, 2022 | 41.00 Mn |
| Mar 31, 2022 | 37.00 Mn |
| Dec 31, 2021 | 46.00 Mn |
| Sep 30, 2021 | 43.00 Mn |
| Jun 30, 2021 | 47.00 Mn |